Your World of Legal Intelligence
 United Kingdom | +44 (0) 20 7284 8080

DCN Dx Acquires Microbiological Testing Products Firm Biomed Diagnostics.

Document Cited in Related
Vincent

MANews-(C)2009-2022

California, US-based point-of-use test developer DCN Dx has completed its acquisition of Oregon, US-based microbiological testing products company Biomed Diagnostics, Inc., the firm said.

The acquisition expands DCN Dx's footprint in the point-of-use testing and sampling markets in both human and veterinary verticals.

Biomed has an established history of developing tools for the surveillance of microorganisms that lead to infectious diseases in humans and animals.

Originally developed for use in low-resource settings, these tools are now recognized for their utility, ease of use, and accuracy.

CN Dx is in the end-to-end development, manufacture, and commercialization of point-of-use tests.

From its headquarters in Carlsbad, California, DCN Dx's cross-functional team of...

To continue reading

Request your trial
COPYRIGHT Normans Media Ltd.

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT